We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Ingersoll Rand Buys Lead Fluid, Strengthens Life Science Platform
Read MoreHide Full Article
Key Takeaways
Ingersoll Rand has acquired Lead Fluid to strengthen its life science business capabilities.
Lead Fluid offers pumps designed for sterile, precise fluid handling in life science applications.
The acquisition supports IR's growth in China and enhances its Precision and Science Technologies segment.
Ingersoll Rand Inc. (IR - Free Report) recently completed the acquisition of Lead Fluid (Baoding) Intelligent Equipment Manufacturing Co., Ltd (Lead Fluid). The financial terms of the transaction have been kept under wraps.
Headquartered in China, Lead Fluid specializes in manufacturing advanced fluid-handling products like peristaltic pumps, gear pumps, syringe pumps and pump heads. Its products are designed for life science applications that require precise fluid delivery and handling of sensitive materials.
Acquisition Rationale
The latest buyout is in sync with Ingersoll Rand’s policy of acquiring businesses to expand its market share and customer base. The inclusion of Lead Fluid’s expertise in advanced fluid-handling products, coupled with its strong innovation capabilities, will enable IR to boost its life science business in China.
Lead Fluid will be incorporated into the company’s Life Sciences platform under the Precision and Science Technologies segment.
Other Notable Buyouts
Acquisitions are an essential aspect of IR’s growth strategy. In October 2024, Ingersoll Rand completed the acquisitions of Air Power Systems (APSCO), Blutek s.r.l. (Blutek) and UT Pumps & Systems Private Limited (UT Pumps). The buyout of APSCO enabled the company to boost its position in the dry and liquid bulk markets with energy-efficient solutions.
With the Blutek buyout, Ingersoll Rand enhanced its competitiveness in high-specification projects by adding technology, expertise and aftermarket opportunities in fast-growing markets like biogas and carbon capture. The UT Pumps buyout enhanced the company’s product portfolio with new pump technology. In first-quarter 2025, acquisitions contributed 8.4% to total revenues.
Zacks Rank, Price Performance and Estimate Revisions
Ingersoll Rand, with approximately $33 billion market capitalization, currently carries a Zacks Rank #3 (Hold). The company is poised to gain from higher orders for industrial vacuums and blowers and strong momentum in the life sciences business. However, a high debt level remains a concern.
Image Source: Zacks Investment Research
In the past month, the company’s shares have gained 7.9% compared with the industry’s growth of 7.2%.
The Zacks Consensus Estimate for its earnings is pegged at $3.32 per share for 2025, indicating a decrease of 2.9% from the 60-day-ago figure.
Stocks to Consider
Some better-ranked stocks from the same space are discussed below.
FSS delivered a trailing four-quarter average earnings surprise of 6.4%. In the past 60 days, the Zacks Consensus Estimate for Federal Signal’s 2025 earnings has increased 1.6%.
Broadwind, Inc. (BWEN - Free Report) presently carries a Zacks Rank of 2. The company delivered a trailing four-quarter average earnings surprise of 61.1%.
In the past 60 days, the consensus estimate for BWEN’s 2025 earnings has increased 14.3%.
The Gorman-Rupp Company (GRC - Free Report) presently carries a Zacks Rank of 2. It has a trailing four-quarter average earnings surprise of 2.4%.
The Zacks Consensus Estimate for GRC’s 2025 earnings has increased by a penny in the past 60 days.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Ingersoll Rand Buys Lead Fluid, Strengthens Life Science Platform
Key Takeaways
Ingersoll Rand Inc. (IR - Free Report) recently completed the acquisition of Lead Fluid (Baoding) Intelligent Equipment Manufacturing Co., Ltd (Lead Fluid). The financial terms of the transaction have been kept under wraps.
Headquartered in China, Lead Fluid specializes in manufacturing advanced fluid-handling products like peristaltic pumps, gear pumps, syringe pumps and pump heads. Its products are designed for life science applications that require precise fluid delivery and handling of sensitive materials.
Acquisition Rationale
The latest buyout is in sync with Ingersoll Rand’s policy of acquiring businesses to expand its market share and customer base. The inclusion of Lead Fluid’s expertise in advanced fluid-handling products, coupled with its strong innovation capabilities, will enable IR to boost its life science business in China.
Lead Fluid will be incorporated into the company’s Life Sciences platform under the Precision and Science Technologies segment.
Other Notable Buyouts
Acquisitions are an essential aspect of IR’s growth strategy. In October 2024, Ingersoll Rand completed the acquisitions of Air Power Systems (APSCO), Blutek s.r.l. (Blutek) and UT Pumps & Systems Private Limited (UT Pumps). The buyout of APSCO enabled the company to boost its position in the dry and liquid bulk markets with energy-efficient solutions.
With the Blutek buyout, Ingersoll Rand enhanced its competitiveness in high-specification projects by adding technology, expertise and aftermarket opportunities in fast-growing markets like biogas and carbon capture. The UT Pumps buyout enhanced the company’s product portfolio with new pump technology. In first-quarter 2025, acquisitions contributed 8.4% to total revenues.
Zacks Rank, Price Performance and Estimate Revisions
Ingersoll Rand, with approximately $33 billion market capitalization, currently carries a Zacks Rank #3 (Hold). The company is poised to gain from higher orders for industrial vacuums and blowers and strong momentum in the life sciences business. However, a high debt level remains a concern.
Image Source: Zacks Investment Research
In the past month, the company’s shares have gained 7.9% compared with the industry’s growth of 7.2%.
The Zacks Consensus Estimate for its earnings is pegged at $3.32 per share for 2025, indicating a decrease of 2.9% from the 60-day-ago figure.
Stocks to Consider
Some better-ranked stocks from the same space are discussed below.
Federal Signal Corporation (FSS - Free Report) currently carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
FSS delivered a trailing four-quarter average earnings surprise of 6.4%. In the past 60 days, the Zacks Consensus Estimate for Federal Signal’s 2025 earnings has increased 1.6%.
Broadwind, Inc. (BWEN - Free Report) presently carries a Zacks Rank of 2. The company delivered a trailing four-quarter average earnings surprise of 61.1%.
In the past 60 days, the consensus estimate for BWEN’s 2025 earnings has increased 14.3%.
The Gorman-Rupp Company (GRC - Free Report) presently carries a Zacks Rank of 2. It has a trailing four-quarter average earnings surprise of 2.4%.
The Zacks Consensus Estimate for GRC’s 2025 earnings has increased by a penny in the past 60 days.